ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,674Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 393

$480K Total Retail Price of All Prescriptions

Rank: 72 out of 393

397 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,045 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
WARFARIN SODIUM 672 557 1 17
LEVOTHYROXINE SODIUM 564 531 2 3
DONEPEZIL HCL 463 448 3 34
FUROSEMIDE 453 412 4 8
LISINOPRIL 359 339 5 2
AMLODIPINE BESYLATE 341 331 6 4
SIMVASTATIN 326 295 7 1
HYDROCODONE-ACETAMINOPHEN 301 267 S3 8 5
OMEPRAZOLE 288 251 9 6
NAMENDA 286 274 10 59
POTASSIUM CHLORIDE 273 228 11 20
METOPROLOL TARTRATE 269 261 12 9
RISPERIDONE 241 178 13 75
GABAPENTIN 227 174 14 15
DIVALPROEX SODIUM 226 175 15 124
METFORMIN HCL 219 219 16 7
SERTRALINE HCL 206 196 17 28
TAMSULOSIN HCL 190 162 18 25
MIRTAZAPINE 186 169 19 89
RANITIDINE HCL 185 145 20 29
CARVEDILOL 180 167 21 21
OXYCODONE HCL 174 161 S2 22 36
CITALOPRAM HBR 172 145 23 23
EXELON 162 162 24 151
DIGOXIN 143 131 25 66
ZOLPIDEM TARTRATE 138 84 26 11
ALENDRONATE SODIUM 126 126 27 16
PANTOPRAZOLE SODIUM 118 108 28 56
MORPHINE SULFATE ER 114 110 S2 29 48
CLOPIDOGREL 109 88 30 33
LOVASTATIN 98 98 31 14
METHADONE HCL 97 87 S2 32 102
LACTULOSE 88 70 33 148
OXYBUTYNIN CHLORIDE 88 50 33 90
AMIODARONE HCL 86 74 35 167
GLIPIZIDE 86 86 35 32
QUETIAPINE FUMARATE 84 65 37 104
ATORVASTATIN CALCIUM 84 72 37 19
LEVETIRACETAM 83 77 39 112
LIDODERM 82 82 40 116
PLAVIX 78 68 41 51
NOVOLIN R 76 76 42 144
KLOR-CON M20 72 72 43 137
ROPINIROLE HCL 72 60 43 121
CLONIDINE HCL 70 67 45 50
LOSARTAN POTASSIUM 70 70 45 12
ATENOLOL 69 47 47 13
NYSTATIN 68 68 48 261
LANTUS 67 63 49 73
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 56 49 111
CYMBALTA 66 64 51 88
FLUOXETINE HCL 63 51 52 37
OXYCODONE-ACETAMINOPHEN 62 61 S2 53 71
HYDRALAZINE HCL 62 62 53 64
FAMOTIDINE 62 51 53 70
DILTIAZEM HCL 61 61 56 175
LEVOFLOXACIN 61 49 56 95
TRAZODONE HCL 60 24 58 47
PROMETHAZINE HCL 60 58 R 58 209
CARBIDOPA-LEVODOPA 59 59 60 142
PAROXETINE HCL 57 57 61 61
MEGESTROL ACETATE 55 42 R 62 182
ESCITALOPRAM OXALATE 54 54 63 133
BACLOFEN 53 17 64 79
AZATHIOPRINE 52 0 65 299
MUPIROCIN 52 25 65 184
PREDNISONE 50 50 67 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.